Search hospitals > New York > Commack
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity)
Claim this profileCommack, New York 11725
Conducts research for Breast Cancer
Conducts research for Lung Cancer
Conducts research for Cancer
Conducts research for MEK1 Gene Mutation
Conducts research for MEK2 Gene Mutation
6 reported clinical trials
4 medical researchers
Summary
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) is a medical facility located in Commack, New York. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, MEK1 Gene Mutation, MEK2 Gene Mutation and other specialties. Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) is involved with conducting 6 clinical trials across 13 conditions. There are 4 research doctors associated with this hospital, such as Paul Paik, Yelena Janjigian, MD, Audree Tadros, MD, and Tali Amir, MD.Area of expertise
1Breast Cancer
adult
solid tumor cancer
known therapy
2Lung Cancer
Stage III
Stage II
HBV DNA negative
Top PIs
Paul PaikMemorial Sloan Kettering Onc. Dept4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
6 reported clinical trials
12 drugs studied
Yelena Janjigian, MDMemorial Sloan Kettering Basking Ridge (Limited Protocol Activities)5 years of reported clinical research
Studies Esophageal Cancer
Studies Stomach Cancer
6 reported clinical trials
11 drugs studied
Audree Tadros, MDMemorial Sloan Kettering Cancer Center2 years of reported clinical research
Studies Breast Cancer
1 reported clinical trial
3 drugs studied
Tali Amir, MDMemorial Sloan Kettering Basking Ridge (Limited Protocol Activities)3 years of reported clinical research
Studies Lung Cancer
Studies Smoking
1 reported clinical trial
1 drug studied
Clinical Trials running at Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity)
Breast Cancer
Lung Cancer
Esophageal Cancer
Stomach Cancer
Adenocarcinoma
Preoperative Radiotherapy + Mastectomy
for Breast Cancer
This trial tests a new treatment for people with advanced breast cancer. It uses radiation to shrink the tumor before surgery and then rebuilds the breast using tissue from another part of the body. The goal is to see if this approach is safe and practical compared to standard treatments.
Recruiting1 award Phase 15 criteria
Pembrolizumab + Trastuzumab + Chemotherapy
for Esophageal Cancer
The purpose of this study to find out whether adding trastuzumab and pembrolizumab to standard chemotherapy is an effective treatment for resectable HER2+ esophagogastric cancer.
Recruiting1 award Phase 27 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity)?
Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) is a medical facility located in Commack, New York. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, MEK1 Gene Mutation, MEK2 Gene Mutation and other specialties. Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activity) is involved with conducting 6 clinical trials across 13 conditions. There are 4 research doctors associated with this hospital, such as Paul Paik, Yelena Janjigian, MD, Audree Tadros, MD, and Tali Amir, MD.